In addition, Harel et al., reported that MFSD2A-associated genotypes and phenotypes imply other factors like nutritional supplementation or modifying genetic factors, such as epigenetic modifications, which may influence the severity of the clinical presentation and proposed to investigate these compensatory mechanisms to treat microcephaly syndromes (20). This evidence concerns the gene MFSD2A and microcephaly.